CGEN vs CMMB: Side-by-Side Comparison
Compare Compugen Ltd (CGEN) and Chemomab Therapeutics Ltd (CMMB) side by side: market cap USD 215.58M vs USD 16.34M. Financials, growth and model signals on Bullrun.
| Metric | CGEN | CMMB |
|---|---|---|
| Company | Compugen Ltd | Chemomab Therapeutics Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 215.58M | USD 16.34M |
| P/E ratio | 6.2 | — |
| Dividend yield | — | — |
| Valuation model | 101.6% undervalued | — |
| Revenue (FY2025) | USD 72.76M | — |
| Revenue growth YoY | +161.1% | — |
| Net income | USD 35.34M | USD -9.00M |
| Gross margin | 87.3% | — |
| Diluted EPS | 0.38 | 0.02 |